Autolus Therapeutics plc
AUTL
$1.75
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 132.94% | 30,872.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 132.94% | 30,872.41% | |||
| Cost of Revenue | -41.88% | -67.69% | |||
| Gross Profit | 85.86% | 74.18% | |||
| SG&A Expenses | 2.48% | -30.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.67% | -2.21% | |||
| Operating Income | 6.16% | 14.01% | |||
| Income Before Tax | 30.05% | -159.85% | |||
| Income Tax Expenses | -82.16% | 52.19% | |||
| Earnings from Continuing Operations | 31.70% | -154.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 31.70% | -154.15% | |||
| EBIT | 6.16% | 14.01% | |||
| EBITDA | 6.53% | 14.67% | |||
| EPS Basic | 31.71% | -154.19% | |||
| Normalized Basic EPS | 30.03% | -161.05% | |||
| EPS Diluted | 31.71% | -154.19% | |||
| Normalized Diluted EPS | 30.03% | -161.05% | |||
| Average Basic Shares Outstanding | 0.01% | -0.03% | |||
| Average Diluted Shares Outstanding | 0.01% | -0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||